Dr. Stella Xu

About

Stella Xu has served on the board of directors of HBM Healthcare Investments since 2020, sitting on its compensation and nomination committees. She holds a doctorate in immunology from Northwestern University and a degree in biophysics from Peking University, and has been managing director of Quan Capital since 2017. Her earlier career included roles at Roche (2002–2017), McKinsey & Company (1998–2002), and Ionis Pharmaceuticals (1996–1998).